The development of an in-situ biopolymer-based floating gel for the oral delivery of metformin hydrochloride
Diabetes remains a global public health threat because of its increasing prevalence and mortality, especially super speciosa sale in people under the age of 25.Metformin hydrochloride (HCl), as recommended by American Diabetes Association in 2022, is the first-line therapy for type 2 diabetes in adults.Metformin has low oral bioavailability due to